Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Innovita Research is developing a mitochondrial transfer technology as part of its cell therapy pipeline. This preclinical-stage program involves the transfer of functional mitochondria between cells as a therapeutic approach to restore cellular bioenergetics and metabolic health. The technology is primarily aimed at treating degenerative diseases and aging-related disorders where mitochondrial dysfunction is a key driver of pathology. Innovita Research, an R&D organization focused on immunology and regenerative medicine, utilizes this approach to ameliorate cellular decay and enhance tissue regeneration by leveraging cellular and subcellular components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mitochondrial transfer technology.